Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers.

Thanks to advances in the understanding of these cancers at the molecular level and to the discovery of several disease-modifying therapeutics, the last decade has seen a plateauing or even a decreasing trend in the number of deaths from these cancers.

also in 47,180 other papers